Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Rubella Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major rubella markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The rubella market has been comprehensively analyzed in IMARC's new report titled 'Rubella Market: Epidemiology, I...

May 2024 139 pages

Sandhoff Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sandhoff disease markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The Sandhoff disease market has been comprehensively analyzed in IMARC's new report titled 'Sandhoff Dise...

May 2024 135 pages

Sanfilippo Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sanfilippo syndrome markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 135 pages

Sarcoidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sarcoidosis markets reached a value of US$ 194.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 289.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.68%...

May 2024 137 pages

Sarcopenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sarcopenia markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% during...

May 2024 128 pages

Scedosporium Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Scedosporium infection markets are expected to exhibit a CAGR of 5.8% during 2024-2034. The Scedosporium infection market has been comprehensively analyzed in IMARC's new report titled 'Sc...

May 2024 140 pages

Schistosomiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major schistosomiasis markets reached a value of US$ 52.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 71.4 Million by 2034, exhibiting a growth rate (CAGR) of 2.92...

May 2024 131 pages

Schizoaffective Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major schizoaffective disorder markets are expected to exhibit a CAGR of 2.21% during 2024-2034. The schizoaffective disorder market has been comprehensively analyzed in IMARC's new report title...

May 2024 137 pages

Schizophrenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major schizophrenia markets reached a value of US$ 9,480.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 15,236.9 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Sciatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sciatica markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.62% during...

May 2024 128 pages

Scleroderma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major scleroderma markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The scleroderma market has been comprehensively analyzed in IMARC's new report titled 'Scleroderma Market: Epi...

May 2024 136 pages

Scoliosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major scoliosis markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3% during 20...

May 2024 129 pages

Seasonal Allergic Rhinitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The seasonal allergic rhinitis market reached a value of US$ 10.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$...

May 2024 140 pages

Seasonal Influenza Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major seasonal influenza markets reached a value of US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 41.6 Billion by 2034, exhibiting a growth rate (CAGR) of 15...

May 2024 133 pages

Seborrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major seborrhea markets are expected to exhibit a CAGR of 7.55% during 2024-2034. The seborrhea market has been comprehensively analyzed in IMARC's new report titled 'Seborrhea Market: Epidemiol...

May 2024 134 pages

Seizures Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major seizures markets reached a value of US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.17% during...

May 2024 132 pages

Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sepsis markets reached a value of US$ 438.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 907.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.84% durin...

May 2024 131 pages

Septic Shock Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major septic shock markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The septic shock market has been comprehensively analyzed in IMARC's new report titled 'Septic Shock Market:...

May 2024 128 pages

Severe Acute Respiratory Syndrome Coronavirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major severe acute respiratory syndrome coronavirus infection markets reached a value of US$ 21.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 68.5 Billion by 2034,...

May 2024 129 pages

Sexually Transmitted Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sexually transmitted disease markets reached a value of US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 95.0 Billion by 2034, exhibiting a growth rate (...

May 2024 128 pages

Sezary Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sezary syndrome markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The Sezary syndrome market has been comprehensively analyzed in IMARC's new report titled 'Sezary Syndrome...

May 2024 140 pages

Short Bowel Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major short bowel syndrome markets are expected to exhibit a CAGR of 20.52% during 2024-2034. The short bowel syndrome market has been comprehensively analyzed in IMARC's new report titled 'Shor...

May 2024 128 pages

Sialidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sialidosis markets are expected to exhibit a CAGR of 6.9% during 2024-2034. The sialidosis market has been comprehensively analyzed in IMARC's new report titled 'Sialidosis Market: Epidemi...

May 2024 134 pages

Sick Sinus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sick sinus syndrome markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 133 pages

Sjogren's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sjogren's syndrome markets reached a value of US$ 168.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 226.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 135 pages

Skin Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major skin neoplasms markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.91% d...

May 2024 139 pages

Sly Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Sly syndrome markets reached a value of US$ 670.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 934.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.07%...

May 2024 135 pages

Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major small cell lung cancer markets reached a value of US$ 8.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.1 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 133 pages

Small Lymphocytic Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major small lymphocytic lymphoma markets are expected to exhibit a CAGR of 2.3% during 2024-2034. The small lymphocytic lymphoma market has been comprehensively analyzed in IMARC's new report ti...

May 2024 140 pages

Smoking Cessation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major smoking cessation markets are expected to exhibit a CAGR of 7.32% during 2024-2034. The smoking cessation market has been comprehensively analyzed in IMARC's new report titled 'Smoking Ces...

May 2024 135 pages

Soft Tissue Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major soft tissue neoplasms markets are expected to exhibit a CAGR of 6.07% during 2024-2034. The soft tissue neoplasms market has been comprehensively analyzed in IMARC's new report titled 'Sof...

May 2024 130 pages

Soft Tissue Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major soft tissue sarcoma markets reached a value of US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5....

May 2024 133 pages

Solid Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major solid tumors markets reached a value of US$ 170.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 375.4 Billion by 2034, exhibiting a growth rate (CAGR) of 7.45%...

May 2024 140 pages

Somatotropin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major somatotropin deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The somatotropin deficiency market has been comprehensively analyzed in IMARC's new report titled...

May 2024 133 pages

Sphingolipidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major sphingolipidoses markets are expected to exhibit a CAGR of 4.01% during 2024-2034. The sphingolipidoses market has been comprehensively analyzed in IMARC's new report titled 'Sphingolipido...

May 2024 140 pages

Spina Bifida In Utero Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spina bifida in utero markets are expected to exhibit a CAGR of 6.59% during 2024-2034. The spina bifida in utero market has been comprehensively analyzed in IMARC's new report titled 'Spi...

May 2024 129 pages

Spinal Cord Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal cord injury markets are expected to exhibit a CAGR of 4.06% during 2024-2034. The spinal cord injury market has been comprehensively analyzed in IMARC's new report titled 'Spinal Co...

May 2024 130 pages

Spinal Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal disorders markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.09%...

May 2024 134 pages

Spinal Muscular Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal muscular atrophy markets reached a value of US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.0 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 129 pages

Spinal Stenosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinal stenosis markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3.12%...

May 2024 131 pages

Spinocerebellar Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spinocerebellar ataxia markets are expected to exhibit a CAGR of 7.45% during 2024-2034. The spinocerebellar ataxia market has been comprehensively analyzed in IMARC's new report titled 'S...

May 2024 140 pages

Spondylolisthesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major spondylolisthesis markets reached a value of US$ 17.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 139 pages

Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major squamous cell carcinoma markets reached a value of US$ 693.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,402.7 Million by 2034, exhibiting a growth rate (C...

May 2024 138 pages

Stargardt Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Stargardt disease markets are expected to exhibit a CAGR of 22.82% during 2024-2034. The Stargardt disease market has been comprehensively analyzed in IMARC's new report titled 'Stargardt...

May 2024 129 pages

Status Epilepticus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major status epilepticus markets reached a value of US$ 884 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,338.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Still's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Still's disease markets are expected to exhibit a CAGR of 3.45% during 2024-2034. The Still's disease market has been comprehensively analyzed in IMARC's new report titled 'Still's Disease...

May 2024 128 pages

Stress Urinary Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major stress urinary incontinence markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The stress urinary incontinence market has been comprehensively analyzed in IMARC's new report...

May 2024 137 pages

Subdural Haematoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major subdural haematoma markets are expected to exhibit a CAGR of 3.61% during 2024-2034. The subdural haematoma market has been comprehensively analyzed in IMARC’s new report titled “Subdural...

May 2024 134 pages

Substance Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major substance use disorder markets reached a value of US$ 5.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 136 pages

Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major surgical site infections markets reached a value of US$ 664.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,174.5 Million by 2034, exhibiting a growth rate (...

May 2024 135 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...